Maryland HB1461 ensures coverage for specialty drugs for rheumatologic conditions when administered by in-network providers.

Maryland HB1461 mandates that insurers, nonprofit health service plans, and health maintenance organizations cover specialty drugs for rheumatologic conditions when administered or dispensed by qualified in-network providers. The bill aims to prevent insurers from steering patients to designated specialty pharmacies, which can lead to treatment delays and errors. It ensures that providers dispensing these drugs within their clinical practice settings receive adequate reimbursement, promoting competition and fairness across dispensing channels.

Maryland HB1461 ensures coverage for specialty drugs for rheumatologic conditions when administered by in-network providers.

Maryland HB1461 mandates that insurers, nonprofit health service plans, and health maintenance organizations cover specialty drugs for rheumatologic conditions when administered or dispensed by qualified in-network providers. The bill aims to prevent insurers from steering patients to designated specialty pharmacies, which can lead to treatment delays and errors. It ensures that providers dispensing these drugs within their clinical practice settings receive adequate reimbursement, promoting competition and fairness across dispensing channels.